Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis — Stella

Home/Pneumoconiosis/

View on ClinicalTrials.gov

Recruiting

Back to Pneumoconiosis trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Beijing China-Japan Friendship Hospital, Beijing

Key details

Phase

Large-scale testing

Sponsor

Beijing Continent Pharmaceutical Co, Ltd.

Enrollment target

~272 participants

Started

June 2022

Primary completion

September 2026

Age range

18 Years – 70 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.